20-34710080-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021202.3(TP53INP2):c.436G>A(p.Glu146Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000188 in 1,275,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021202.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TP53INP2 | NM_021202.3 | c.436G>A | p.Glu146Lys | missense_variant | 5/5 | ENST00000374810.8 | |
TP53INP2 | NM_001329429.2 | c.436G>A | p.Glu146Lys | missense_variant | 5/5 | ||
TP53INP2 | NM_001329430.2 | c.436G>A | p.Glu146Lys | missense_variant | 4/4 | ||
TP53INP2 | NM_001329431.2 | c.436G>A | p.Glu146Lys | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TP53INP2 | ENST00000374810.8 | c.436G>A | p.Glu146Lys | missense_variant | 5/5 | 1 | NM_021202.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151430Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000222 AC: 1AN: 44986Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 26538
GnomAD4 exome AF: 0.0000169 AC: 19AN: 1124396Hom.: 0 Cov.: 33 AF XY: 0.0000166 AC XY: 9AN XY: 543692
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151430Hom.: 0 Cov.: 32 AF XY: 0.0000406 AC XY: 3AN XY: 73912
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 24, 2023 | The c.436G>A (p.E146K) alteration is located in exon 5 (coding exon 3) of the TP53INP2 gene. This alteration results from a G to A substitution at nucleotide position 436, causing the glutamic acid (E) at amino acid position 146 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at